Skip to main content
. 2008 Jun 28;23(9):1339–1345. doi: 10.1007/s11606-008-0681-2

Table 1.

Baseline Characteristics of New-onset DM Type 2 Patients in Four Dominant First-year Weight Trajectories

Characteristic Weight-change pattern
Higher stable weight Lower stable weight Weight gain Weight loss P value*
N 757 2,236 664 478
Age, mean ± SD 52.7 ± 9.7 57.7 ± 10.2 53.9 ± 9.7 55.9 ± 9.7 <0.001†
Gender (% female) 330 (43.6) 1316 (58.9) 258 (38.9) 251 (52.5) <0.001†
Baseline weight lbs, mean ± SD 285.4 ± 43.1 194.2 ± 33.8 231.2 ± 39.4 235.8 ± 45.9 <0.001
Baseline BMI‡ <0.001†
 BMI < 25 0 (0.0) 171 (7.6) 11 (1.7) 7 (1.4)
 25 ≤BMI < 30 8 (1.0) 666 (29.8) 119 (17.9) 54 (11.3)
 30 ≤BMI < 40 267 (35.3) 1213 (54.3) 378 (56.9) 267 (55.9)
 BMI ≥ 40 482 (63.7) 186 (8.3) 156 (23.5) 150 (31.4)
Race-risk, n (%)§ 31 (4.1) 151 (6.8) 46 (6.9) 18 (3.8) 0.006†
Income (% family income <$40K) 151 (20.0) 407 (18.2) 136 (20.5) 65 (13.6) 0.02†
Smoking (current), n (%) 134 (17.7) 425 (19.0) 162 (24.4) 74 (15.5) <0.001†
Medications, mean ± SD 8.3 ± 5.5 7.8 ± 5.5 8.4 ± 6.1 7.4 ± 5.3 0.005†
Depression, n (%) 121 (16.0) 285 (12.8) 106 (16.0) 56 (11.7) 0.02†
Hypertension, n (%) 428 (56.5) 1067 (47.7) 307 (46.2) 249 (52.1) <0.001
Dyslipidemia, n (%) 165 (21.8) 606 (27.1) 153 (23.0) 85 (17.8) <0.001†
CVD (excluding CHF)║, n (%) 78 (10.3) 270 (12.1) 80 (12.1) 50 (10.5) 0.48
Microvascular disease, n (%) 69 (9.1) 155 (6.9) 38 (5.7) 30 (6.3) 0.07
Asthma/COPD/Arthritis,¶ n (%) 219 (28.9) 548 (24.5) 182 (27.4) 108 (22.6) 0.03

*Comparison across all four groups (group patterns determined through cluster analysis)

†Comparison of weight-gain compared to weight-loss groups also significant at p < 0.05

‡BMI = body mass index

§Defined as Black/Hispanic/American Indian/Pacific Islander

║CVD = cardiovascular disease, CHF = congestive heart failure

¶Combined non-cardiovascular diagnoses that may interfere with activity; chronic obstructive pulmonary disease (COPD)